All of these studies have found that chr22q/NF2 loss does not co-occur with TRAF7, AKT1, KLF4, SMO, or POLR2A mutations, which were all found in benign meningiomas (Figure 1) [36,37,38,39,40]. The gene discussed is NF2; the disease is benign meningioma.